tolbutamide has been researched along with Delayed Effects, Prenatal Exposure in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giampietro, PF | 1 |
| Bruns, CM | 1 |
| Baum, ST | 1 |
| Colman, RJ | 1 |
| Eisner, JR | 1 |
| Kemnitz, JW | 1 |
| Weindruch, R | 1 |
| Abbott, DH | 1 |
2 other studies available for tolbutamide and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
50 Years Ago in The Journal of Pediatrics: Tolubtamide-Mediated Dysregulation of Apoptosis.
Topics: Adult; Apoptosis; Female; Humans; Hypoglycemic Agents; Infant, Newborn; Male; Pregnancy; Prenatal Ex | 2020 |
Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys.
Topics: Animals; Area Under Curve; Female; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; In | 2004 |